Gastrointestinal and Other Cancers Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration NCT02965703 National Cancer Institute (NCI) Recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration NCT02521285 National Cancer Institute (NCI) Active, not recruiting
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission Berberine Chloride, Laboratory Biomarker Analysis, Placebo Administration NCT02365480 National Cancer Institute (NCI) Active, not recruiting
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... Curcumin, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Placebo Administration NCT02782949 National Cancer Institute (NCI) Active, not recruiting
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03278925 National Cancer Institute (NCI) Recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid NCT02772003 National Cancer Institute (NCI) Active, not recruiting
Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers Laboratory Biomarker Analysis, Questionnaire Administration, Dolcanatide, Placebo Administration NCT03300570 National Cancer Institute (NCI) Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Erlotinib NCT02273362 National Cancer Institute (NCI) Active, not recruiting
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... Erlotinib Hydrochloride, Erlotinib NCT02961374 National Cancer Institute (NCI) Active, not recruiting
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer Genistein, Laboratory Biomarker Analysis, Pharmacological Study, Placebo Administration, Therapeutic Conventional Surgery NCT00118040 National Cancer Institute (NCI) Active, not recruiting

Pages